REVOLADE 50MG
ELTROMBOPAG
Public price
14.699,00 MAD
Reimbursement base
14.699,00 MAD
Active substance
ELTROMBOPAG
What is this medicine?
Eltrombopag is a thrombopoietin receptor agonist used to treat thrombocytopenia associated with immune thrombocytopenia, chronic hepatitis C, and severe aplastic anemia.
Verified summary
ELTROMBOPAG, COMPRIME PELLICULE, 50 MG, 1 BOITE 28 COMPRIME PELLICULE
Common uses
Treatment of thrombocytopenia in adult and pediatric patients (1 year and older) with persistent or chronic immune thrombocytopenia (ITP),Treatment of thrombocytopenia in patients with chronic hepatitis C to allow initiation and maintenance of interferon-based therapy,First-line treatment of severe aplastic anemia in adult and pediatric patients (2 years and older) in combination with standard immunosuppressive therapy,Treatment of severe aplastic anemia in patients who have had an insufficient response to immunosuppressive therapy
Class
thrombopoietin receptor agonist
Hospital price
9.724,00 MAD
Strength
50 MG
Form
COMPRIME PELLICULE
Presentation
1 BOITE 28 COMPRIME PELLICULE
Type
P
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2017-12-18: 14.699,00 MAD